Although sexual functioning is an important facet of a living donor's quality of life, it has not received an extensive evaluation in this population. Using data from the Adult-to-Adult Living Donor Liver Transplantation Cohort Study, we examined donor sexual functioning across the donation process from the predonation evaluation to 3 months and 1 year after donation. Donors (n 5 208) and a comparison group of nondonors (n 5 155) completed self-reported surveys with specific questions on sexual desire, satisfaction, orgasm, and (for men) erectile function. Across the 3 time points, donor sexual functioning was lower at the evaluation phase and 3 months after donation versus 1 year after donation. In the early recovery period, abdominal pain was associated with difficulty reaching orgasm [odds ratio (OR), 3.98; 95% confidence interval (CI), 1.30-12.16], concerns over appearance were associated with lower sexual desire (OR, 4.14; 95% CI, 1.02-16.79), and not feeling back to normal was associated with dissatisfaction with sexual life (OR, 3.58; 95% CI,). Efforts to educate donors Additional Supporting Information may be found in the online version of this article.
before the surgery and prepare them for the early recovery phase may improve recovery and reduce distress regarding sexual functioning. Liver Transpl 21:670-682, 2015. V C 2015 AASLD.
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Living liver donors offer a portion of their own healthy liver to save the life of another. Because donors make a personal sacrifice to enhance the welfare of another, efforts to prevent adverse health and quality-of-life outcomes are essential. Much has been written about the health-related quality of life (HRQOL) of donors, their typically high levels of functioning before and after donation, and their often quick physical recovery. [1] [2] [3] [4] [5] [6] [7] However, to date, there has been little examination of donor sexual functioning through the donation process. A single-center study that included 1 question about whether donation had affected sexual function or intimacy showed that nearly 50% of donors reported worsened sexual functioning 1 week to 1 month after donation, but most reported a return to the baseline at 3 months after donation. 2 A retrospective cross-sectional survey of liver donors' HRQOL that asked a single question about sexual functioning found that those who reported a lower perception of body image and cosmesis reported significantly greater interference in their sex lives. 8 Thus, with the intent to identify the scope and extent of donor sexual concerns, we examined donor sexual functioning before and after donation with the multisite Adult-to-Adult Living Donor Liver Transplantation Cohort Study (A2ALL). The purpose of our study was (1) to describe the sexual functioning of liver donors, including changes through the first year after donation, and (2) to evaluate whether and to what extent donation-related factors (eg, self-reported recovery from the surgery, physical symptoms, pain, appearance, and health concerns) were associated with poorer sexual functioning.
PATIENTS AND METHODS

Study Design and Cohort Definitions
The A2ALL consortium consisted of 9 North American transplant centers with data collected on potential living liver donors and their recipients. Patients were recruited from 2004 to 2009 with follow-up through August 2010. All individuals evaluated for living liver donation at these centers were asked to complete HRQOL surveys, including sexual functioning questions. Potential donors could enter the study during the donor evaluation process or at a later time point if they had already donated. Surveys were administered at evaluation and at 3 months and 1 year after donation and at evaluation and 3 months and 12 months after evaluation for those who did not donate (nondonors). For participants who enrolled after donation, the surveys were administered according to the protocol visit schedule and were started with the visit window after donation. Clinical information, including data on donor hospitalizations, complications, and recipient outcomes, was collected from the medical record, which was supplemented with data from the Scientific Registry of Transplant Recipients.
Of the 971 consenting potential donors, 170 were excluded because they enrolled in the A2ALL protocol more than 2 years after donation or evaluation and were beyond the time points of interest (Fig. 1 ). An additional 142 nondonating candidates were excluded because of factors that may have made their reports of sexual functioning less comparable to those of actual donors; for example, those who declined to donate or were rejected as donors for medical or psychosocial contraindications were excluded. Of the remaining 659 who were eligible to be donors, 293 were donors, and 366 were nondonors. Nondonors did not donate mostly because of recipient (eg, the recipient received a deceased donation) or anatomical reasons. Surveys were completed at the evaluation phase before it was known that the nondonors would not donate. We chose nondonors to be the control group because they would be similar to the donor group with respect to health and psychological functioning. Donors are healthier than the general population of age-matched individuals because they are specifically screened to not have medical or psychosocial issues. Thus, a comparable group would be eligible donors who eventually did not donate mostly because of recipient reasons and not because they had medical or psychological issues that prevented them from donating. Of those, 208 donors (71%) and 155 nondonors (42%) completed at least 1 sexual functioning questionnaire and were included in the analyses. There were no statistical differences between responders and nonresponders in demographics or for donors in postdonation factors (complications, hospitalizations, or recipient death/retransplantation).
Human Subjects Protection
A2ALL, which collected the data in the present report, was approved by the institutional review boards and privacy boards of the University of Michigan Data Coordinating Center and each of the 9 participating transplant centers. All participants provided written informed consent.
Instruments and Measures (see Table 1 )
Surveys were self-administered. The questions were preceded by a statement that responses would be kept confidential and not revealed to the transplant team.
Sexual Functioning Questions
Of the component parts of sexual activity, desire, erectile function (for men), and overall sexual satisfaction are considered some of the most important dimensions of sexual functioning. 9 Self-report surveys are considered one of the most valid ways to assess sexual functioning. 9 Specific questions addressing each of these areas for men and women were developed and validated by expert sexuality researchers, 9,10,13 and they have been used in studies of sexual functioning after general and urological/gynecological surgery. [14] [15] [16] Donors were surveyed with 4 of these questions covering core sexual functioning areas: 3 assessed both men and women (orgasmic function, desire, and overall satisfaction), and a fourth item assessed men (erectile function). The time frame for each item was the prior month. We dichotomized responses on each sexual functioning item into those endorsing the item half the time or less (poorer sexual functioning) versus those endorsing better sexual functioning. For questions about erectile and orgasmic function, responses of no sexual activity (either stimulation or intercourse) were included in the poorer functioning group. The question on satisfaction with sex life was dichotomized as satisfied versus neutral or dissatisfied.
Postdonation Covariates: Symptoms and Concerns
Postdonation surveys included items on recovery (fully recovered versus not), being physically back to normal (yes versus no), pain (any versus none), pain interference with functioning (any versus never), bowel symptoms interfering with functioning (any versus never), and physical appearance (same/better versus worse). Symptoms of depression were elicited with 2 screening questions from the Mini-International Neuropsychiatric Interview 12 on the 2 cardinal symptoms of depression required for the clinical diagnosis (present or not; see Table 1 ).
Several validated instruments assessing donationspecific concerns (eg, relationships, satisfaction with donation, and health concerns related to donation) 11 have been used extensively in bone marrow, [17] [18] [19] [20] kidney, 21, 22 and liver 23, 24 donation research. From these instruments, we chose health concerns related to the donation experience as the most relevant to sexual functioning. Four individual items representing the donationrelated health concerns domain were assessed: the future negative effects of donation on health (agree versus disagree), worries about current health (any worries versus none), frequency of worries (often to sometimes versus almost never), and worries about never feeling physically 100% again (agree versus disagree).
Demographic and Donor Medical Outcomes
Basic demographics, the relationship with the actual/ intended recipient, medical comorbidities, smoking (1998) Have you been consistently depressed or down, most of the day, nearly every day, for the past 2 weeks? Yes No status, and body mass index (BMI) were obtained from medical records. Marital/relationship status and educational level were asked by survey. For donors, data on the liver lobe donated, medical complications (number and Clavien grade), number of rehospitalizations, and recipient status at follow-up (alive, deceased, or retransplanted) were collected from medical record reviews. Donors were asked about current pain medication usage. After donation, women were asked whether they were pregnant or attempting to become pregnant.
Data Considerations
A2ALL represents 79% of living donors from the corresponding era. Those who did and did not enroll in A2ALL were similar in age (37.4 6 10.1 and 36.2 6 10.3 years, respectively; P 5 0.43), and similar percentages were enrolled by sex (80% among females and 77% among males; P 5 0.53). However, white, native, and multiracial donors were more likely to enroll (82%) than blacks (63% of 16 donors) or Asians (36% of 14 donors; P < 0.001). Of the 208 donors analyzed, 122 completed the questionnaire at the evaluation, 105 completed it 3 months after donation, and 107 completed it 1 year after donation. Eighty-two donors responded at the evaluation and at least 1 postdonation time point of interest (3 months and/or 1 year after donation). Of the 155 nondonors, 134 responded at the evaluation, 21 responded 3 months after the evaluation, and 13 responded 1 year after the evaluation. Only 13 nondonors responded at multiple time points, and only 12 responded at the evaluation and 1 postevaluation time point; thus, there were too few nondonors to consider for the longitudinal analyses. Among eligible donors and nondonors, no significant differences existed between those analyzed or excluded in the demographic variables in Table 2 .
To maximize response rates, surveys were administered in several formats: tablet computers (n 5 341), paper forms (n 5 157), and a web-based format (n 5 4). No statistical differences existed between the tablet and paper formats for any of the sexual functioning questions.
Statistical Analysis
Characteristics of donors and nondonors were compared with t tests for continuous variables and with chi-square or Fisher's exact tests for categorical variables. Graphs of the proportion indicating poorer sexual function included standard error (SE) bars based on the binomial distribution.
Potential predictors of poor sexual function were first evaluated at each time point for each question. Both donors and nondonors were included in models at evaluation; only donors were included in postdonation models. Covariates considered included donation age, sex, race, ethnicity, relationship to recipient, marital status, education, BMI, smoking history, history and current symptoms of depression, and dyslipidemia. Diabetes, pulmonary disease, heart disease, and hypertension were uncommon and not tested. Covariates considered for the postdonation models additionally included the lobe donated and measures from the given survey or earlier: number of hospitalizations, number of complications (overall and severity), medications for pain, recipient death or retransplant, depressive symptoms, abdominal pain, bowel symptoms, concerns about appearance, and donation-related worries. Variable selection used the method of best subsets, 25 with sex retained even if not significant. Results are presented as odds ratios (ORs) with 95% confidence intervals (CIs).
To investigate changes in the probability of poorer sexual function following donation, repeated measures logistic models were fit to the subgroup with the evaluation and at least 1 postdonation survey; a compound symmetry covariance structure was used. This method yields unbiased inference even if subjects have missing surveys at some time points under the assumption that the missing data mechanism is ignorable. The covariates considered previously were tested with adjustments for sex and time point. The interactions between sex and time were tested but were not found to be significant. Results are presented as predicted probabilities of poorer sexual function, with P values given for tests of sex differences and pairwise time point differences. Predonation sexual function was also tested as a predictor of postdonation function with a similar model that included predonation function as a covariate.
RESULTS
Descriptive Results
Donors and nondonors were similar in most baseline demographic characteristics. They were predominantly white, were evenly divided between men and women, and were on average 37.7 years old ( Table 2) . Only 0% to 3% had medical comorbidities of diabetes, pulmonary disease, heart disease, or hypertension. Dyslipidemia (7% of both groups) was not significantly associated with sexual functioning. The majority intended to donate to a biological relative, and a small percentage intended to donate to a spouse. Compared to nondonors, donors were more likely to be white and unmarried. Three female donors reported attempting to get pregnant in the year after donation.
Among donors, most donated the right lobe of their liver, and after the initial donation hospitalization, most were not hospitalized again during the first year (Table 3) . Most complications occurred within the first 3 months, with 36% experiencing at least 1 complication within the first year. The highest grade complication was Clavien grade 2 (21% in the first year).
26 By 1 year, 5% of the living liver donor recipients had died, and another 5% were retransplanted. Few donors reported symptoms of depression or concerns about appearance. However, bowel symptoms and pain were common. At 1 year, 40% reported bowel symptoms, and 46% reported abdominal pain that interfered with everyday life. Nevertheless, at 1 year, 75% felt back to normal. Most felt that their recovery pace was as expected or faster. Although few worried that they would never feel physically 100% again, at 3 months, 35% were at least a little worried about their health, and 42% worried about the physical effects of donation.
What Are the Prevalence and Specific Types of Sexual Concerns/Problems Both Before and After Liver Donation? Males were less likely to report poorer sexual functioning than females for all questions at all time points except in the area of sexual satisfaction. The percentage feeling poorer sexual desire was higher at 3 months versus the evaluation for both males and females but dropped at 1 year for both. This phenomenon was not as evident for the other 3 questions. Table 4 shows results for the 4 sexual function questions at evaluation. There were no significant differences between donors and nondonors in any of the 4 areas of sexual functioning. Females were significantly more likely than males to report problems with sexual desire and difficulty achieving orgasm, whereas males were more likely to be dissatisfied with their overall sex life. Unmarried respondents had a higher probability of having problems with getting an erection or reaching orgasm and of being dissatisfied with their sex life. Respondents whose intended recipient was their spouse had a significantly higher probability of being dissatisfied with their sex life. Race was significant only in predicting erection in males, with nonwhites having greater odds of lower erectile function.
What Variables Predict Poorer Sexual Function at Evaluation?
What Is the Association Between Poorer Sexual Functioning After Donation and DonationSpecific Factors? Table 4 shows models for the 3-month and 1-year postdonation time points. We examined correlates, including recovery time, complications, pain, physical symptoms, view of physical appearance, and worries about health. At 3 months, concerns about appearance, abdominal pain, and not feeling back to normal were associated with reporting poorer sexual functioning. Donors who felt that their appearance was worse or much worse were significantly more likely to report lower sexual desire (OR, 4.14; 95% CI, 1.02-16.79), and donors whose abdominal pain interfered with their daily life were more likely to report difficulty reaching orgasm (OR, 3.98; 95% CI, 1.30-12.16). Donors who did not feel back to normal at 3 months were more likely to report dissatisfaction with their sexual life (OR, 3.58; 95% CI, 1.43-8.99).
At 1 year, no donation-specific variables were significantly associated with sexual functioning, although the effect of not feeling back to normal was attenuated from the effect seen at 3 months (OR, 2.80; 95% CI, 0.94-8.37).
What Are the Probabilities of Poorer Sexual Functioning at the 3 Time Points and How Do These Differ Before and After Donation?
We tested for differences in the probability of poorer sexual functioning over time and adjusted for sex (Table 5) . For all 4 questions, no significant differences existed between the probabilities of poor sexual functioning at 3 months versus the evaluation. The probability of poor sexual desire decreased at 1 year with respect to the evaluation (P < 0.001) and 3 months (P 5 0.001). This trend was seen in the other 3 questions but did not reach significance. Females had a higher probability of poorer sexual function than males, but this difference was significant only in the areas of sexual desire and reaching orgasm (Table 5) .
Does Sexual Functioning at Evaluation Predict Sexual Functioning in the First Year After Donation?
Poorer sexual functioning at evaluation was strongly associated with a higher probability of poorer sexual functioning in the first year after donation in the areas of sexual desire (OR, 5.69; 95% CI, 1.46-22.21) and satisfaction with sex life (OR, 5.12; 95% CI, 1.56-16.77), with adjustments for sex and time.
Sensitivity Analysis
As a sensitivity analysis, participants who reported no sexual activity for erectile and orgasmic function were excluded from the 3 sets of models in Table 4 (n 5 31 nondonors, n 5 41 donors). The results were largely unchanged, with some previously marginally significant variables becoming nonsignificant, likely because of the reduction in sample size. More importantly, the magnitude and direction of the effects remained the same. Most respondents who completed surveys at more than 1 time point did not consistently report having no sexual activity on all of their surveys. Additional testing showed that those included in the longitudinal models did not have significantly different sexual functioning than those who responded at only 1 time point.
DISCUSSION
Living donors differ from other surgical patients because they undergo their procedure without any Figure 2 . Percentage of subjects showing difficulty in sexual functioning, which was defined as responding half the time or less on desire, erection, and orgasm questions and neutral, dissatisfied, or very dissatisfied on the sexual satisfaction question. SE bars were calculated with the normal approximation to the binomial distribution. expectation of health benefit. Although an extensive literature exists on sexual functioning recovery after types of abdominal/genitourinary surgery known to affect sexual functioning (eg, prostate, urological, hysterectomy, and colostomy), this literature is less relevant for living liver donors, who go into the procedure in good health. The present data provide a more comprehensive understanding of the sexual issues of living liver donors than previously available. We asked participants questions on key domains of sexual functioning important to patients. These data can provide a useful basis for developing future psychoeducational interventions to prepare donors for the postoperative recovery period. Overall, donors were most likely to report poorer sexual functioning at the evaluation phase and at 3 months after donation, but they were least likely to report problems at 1 year. Donors who had poorer sexual functioning at evaluation continued to have poorer function in the early 3-month recovery period but were less likely to have these issues by 1 year. Although donors typically report high levels of physical and emotional functioning before donation (in fact, they are selected for these features), the fact that both donors and nondonors reported poorer sexual functioning at the evaluation phase demonstrates that some areas of psychosocial functioning are not optimal and might be affected by the stresses inherent in the decision to donate and the evaluation process. Prior studies of donor stress and anxiety show the predonation period to be the most stressful for donors, with a reduction in distress within the early months after donation. 1, 3 Differences at evaluation did not persist after donation, except that females were consistently more likely to report poorer levels of sexual desire. Because there are no inherent differences between males and females in the level of sexual functioning, 9,10 this suggests that possible issues related to the donation experience are contributing to these results. That both sexes experienced difficulties at evaluation versus the other time points suggests that this stressful time period affects both sexes but perhaps somewhat differently. A prior investigation of sex differences determined that at the predonation phase, women were more likely to be concerned about the donation's impact on their family and social obligations. 24 Although we did not ask about specific stresses reflecting women's various roles in their families with respect to caregiving responsibilities, such issues may continue after donation and affect sexual desire.
Those with donation-related complaints (abdominal pain, concerns about appearance, and not feeling back to normal again) reported lower levels in several areas of sexual functioning. Consistent with the existing liver donor literature that shows decrements in physical functioning in the immediate postoperative period (typically the first 3 months) with recovery to baseline levels within 1 year, 1 donors may expect that until they are feeling physically better and back to normal, aspects of normalcy such as sexual functioning may be decreased. Although we hypothesized that donor concerns about their recovery and the impact of donation on their current and future health would be associated with poorer sexual functioning, this was not the case.
Limitations
Missing surveys in the data set and especially the lack of longitudinal data for the nondonors are a limitation. However, we were able to use analytic techniques to make the best use of all available data. We did not have data on donors and nondonors who did not enroll in A2ALL. Additionally, A2ALL had fewer minorities represented in comparison with all donors during that era, and this may also have introduced a bias. It is important to note that the baseline sexual functioning of donors before they entered the donation evaluation process is unknown. Donor concerns over the evaluation process, their own future health and well-being, and the health and well-being of the intended recipients may have affected their responses. It is, therefore, possible that donor baseline sexual functioning was higher than that at evaluation, and this might explain the improvement of sexual functioning after 1 year above the scores at evaluation. Although comprehensive sexual functioning instruments exist, in an effort not to overburden respondents, a smaller set of sexual functioning items was chosen. However, the questions asked capture key domains representing sexual functioning. Similarly, data on the specifics of how postdonation factors, such as aspects of physical appearance, may have influenced the donors' sexual functioning were not obtained. We did not have data on antihypertensive or antidepressant medication usage, but these medical issues were uncommon in our cohort and unlikely to affect the findings. It is possible that some participants experienced embarrassment or discomfort when they were responding to sexual functioning questions, and this may have altered their answers or willingness to respond at all. In addition, the questions do not specify whether they refer to sexual functioning with a consistent partner or other patterns of sexual activity. However, these items have been used widely in both interviewer-driven and self-reporting formats.
In conclusion, sexual function questions are likely not a routine part of donor surgical follow-up. Although patients might wish to speak with their physicians/clinicians about their sexual functioning concerns, these conversations are infrequently initiated by the patient, and clinicians must be sensitive to the need to ask. Additionally, the focus of a typical postdonation follow-up examination may be on known or expected complications, with less consideration of the broader impact of the surgery on a range of functions such as sexual activity. Thus, close monitoring during early recovery with inquiries into sexual functioning issues will provide donors an opportunity to report any problems and allow them to discuss concerns. Awareness that the inherent stresses in the predonation phase may have effects on sexual functioning is important. Educating donors on what to expect with sexual functioning, specifically early in recovery, will probably not lessen these problems but will allow donors to understand and prepare for this phase of their recovery. Donor teams might consider interventions to minimize scarring, prevent hernias, and prepare for postdonation physical appearance to decrease the impact of concerns over appearance on sexual desire. Efforts to educate the donors' sexual partners may also help to relieve/reduce anxieties and normalize expectations. As we work to maximize the positive psychological and physical experiences associated with living donation, efforts toward reducing stress by educating donors on what is expected and normal and what are anticipated outcomes are the goals of all donor teams. Appreciating that sexual functioning is an essential aspect of donor quality of life directs our focus toward this important area.
